In Vitro
                    and
                    In Vivo
                    Activities of DS-2969b, a Novel GyrB Inhibitor, and Its Water-Soluble Prodrug, DS11960558, against Methicillin-Resistant
                    Staphylococcus aureus

Tarani Kanta Barman; Manoj Kumar; Tarun Mathur; Eiko Namba; Diksha Singh; Tridib Chaira; Yuichi Kurosaka; Makiko Yamada; Dilip Jatashankar Upadhyay; Nobuhisa Masuda

doi:10.1128/aac.02556-17

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain langauage summary to help more people find, understand and use it.

This page is a summary of: In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, and Its Water-Soluble Prodrug, DS11960558, against Methicillin-Resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, April 2018, ASM Journals, DOI: 10.1128/aac.02556-17.
You can read the full text:

Read

Contributors

The following have contributed to this page

Nobuhisa Masuda
Daiichi Sankyo Kabushiki Kaisha

In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, and Its Water-Soluble Prodrug, DS11960558, against Methicillin-Resistant Staphylococcus aureus

Publication not explained

Featured Image

Read the Original

Contributors

Share this page:

You might also like

Antiretroviral drug resistance mutations among patients failing first-line treatment in Hanoi, Vietnam

Enhanced In‐vivo Optical Imaging of the Inflammatory Response to Acute Liver Injury in C57Bl/6 Mice using a Highly Bright Near‐Infrared BODIPY Dye

The natural product trienomycin A is a STAT3 pathway inhibitor that exhibits potent in vitro and in vivo efficacy against pancreatic cancer